
Compare CareTrust REIT's latest earnings beat and new capital access with other real estate and income opportunities by reviewing 39 high quality undervalued stocks in similar sectors.
To own CareTrust REIT, you need to believe its multi engine model across U.S. skilled nursing, U.K. care homes and SHOP can keep turning new investments into steady rent and FFO without eroding coverage ratios. The Q3 FFO beat and raised guidance reinforce that thesis, but also raise the bar for execution on the enlarged portfolio.
The key near term catalyst is how quickly the roughly US$2.9b of 2026 deployment, including the U.K. care homes, settles into stable cash flow. The biggest current risk is deal quality and pricing. If high yielding opportunities become scarce or tenant metrics soften, external growth could translate into less attractive per share outcomes.
The fourth amended and restated US$2.0b unsecured revolving credit facility is the announcement that matters most here. It extends maturities out to 2030 to 2032 on the term loans and gives CareTrust REIT a long dated, largely undrawn pool of liquidity to fund acquisitions, refinance existing obligations and support its U.S. and U.K. pipeline.
For you as an investor, that facility directly links to both catalysts and risk. It supplies capacity to pursue more high yield skilled nursing and U.K. care home opportunities, while the covenant package and floating rate spreads keep discipline around leverage and interest coverage. The trade off is clear: a model reliant on external funding lives or dies on prudent deployment and tenant health.
CareTrust REIT's narrative projects US$1.0b revenue and US$575.5 million earnings by 2029. This assumes revenue growth of 20.9% per year and an earnings increase of about US$220 million from the current US$355.6 million level.
Uncover why CareTrust REIT's fair value indicates a 15% potential upside to its current price before other investors close that discount gap.
Simply Wall St Community members offer only two fair value views so far, stretching from about US$43.79 to US$98.80 per share, which is a wide bracket for CareTrust REIT. That small sample sits beside a bigger story: heavy external investment and the enlarged credit facility can either support earnings resilience or magnify deal selection risk. Readers should explore several of these alternative viewpoints before taking a position on the valuation debate.
Explore another CareTrust REIT fair value estimate, including one that suggests as much as 159% upside from the current price!
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If you want to stress test your CareTrust REIT view against other opportunities, broaden your watchlist with a few focused stock lists that line up with your income, quality or risk priorities.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com